Chicago Partners Investment Group’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$575K Buy
7,479
+854
+13% +$65.7K 0.02% 542
2025
Q1
$497K Sell
6,625
-967
-13% -$72.6K 0.02% 517
2024
Q4
$563K Buy
7,592
+537
+8% +$39.8K 0.02% 470
2024
Q3
$498K Buy
7,055
+542
+8% +$38.3K 0.02% 491
2024
Q2
$414K Buy
6,513
+375
+6% +$23.9K 0.02% 517
2024
Q1
$539K Buy
6,138
+1,723
+39% +$151K 0.02% 425
2023
Q4
$320K Sell
4,415
-307
-7% -$22.3K 0.01% 528
2023
Q3
$326K Sell
4,722
-66
-1% -$4.56K 0.02% 494
2023
Q2
$385K Buy
4,788
+187
+4% +$15K 0.02% 475
2023
Q1
$409K Sell
4,601
-235
-5% -$20.9K 0.02% 432
2022
Q4
$387K Sell
4,836
-865
-15% -$69.2K 0.02% 431
2022
Q3
$392K Buy
5,701
+773
+16% +$53.2K 0.03% 391
2022
Q2
$495K Buy
4,928
+24
+0.5% +$2.41K 0.04% 332
2022
Q1
$458K Buy
4,904
+182
+4% +$17K 0.04% 331
2021
Q4
$509K Buy
4,722
+51
+1% +$5.5K 0.04% 330
2021
Q3
$534K Buy
4,671
+30
+0.6% +$3.43K 0.04% 324
2021
Q2
$505K Buy
4,641
+27
+0.6% +$2.94K 0.04% 325
2021
Q1
$443K Buy
4,614
+1,252
+37% +$120K 0.04% 322
2020
Q4
$288K Buy
3,362
+139
+4% +$11.9K 0.03% 373
2020
Q3
$239K Sell
3,223
-121
-4% -$8.97K 0.03% 357
2020
Q2
$263K Sell
3,344
-37
-1% -$2.91K 0.03% 313
2020
Q1
$257K Buy
3,381
+777
+30% +$59.1K 0.04% 279
2019
Q4
$207K Buy
+2,604
New +$207K 0.03% 344
2018
Q4
Sell
-2,007
Closed -$93K 509
2018
Q3
$93K Buy
2,007
+3
+0.1% +$139 0.01% 427
2018
Q2
$97K Hold
2,004
0.02% 392
2018
Q1
$93K Hold
2,004
0.02% 361
2017
Q4
$75K Hold
2,004
0.01% 397
2017
Q3
$73K Buy
+2,004
New +$73K 0.01% 383
2017
Q2
Sell
-1,629
Closed -$51K 682
2017
Q1
$51K Hold
1,629
0.01% 311
2016
Q4
$51K Buy
+1,629
New +$51K 0.02% 299